DBV Technologies reported EUR-1.55 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amarin USD -0.03 0.01 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
DBV Technologies EUR -1.55 0.25 Jun/2025
Halozyme Therapeutics USD 1.54 0.43 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Insmed USD -1.7 0.28 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
United Therapeutics USD 6.41 0.22 Jun/2025